| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
💡 Key Pearls:
⭐ AV fistula = longest survival, lowest infection.
🚫 Never use fistula arm for BP, bloods, or IV lines.
🚫 Avoid subclavian lines (stenosis risk).
📞 Urgently refer access issues to vascular team.
📍 Central Venous Catheter (CVC)
✔️ Immediate access, no maturation needed.
❌ Infection + thrombosis, poor long-term patency, central stenosis.
➡️ Used for AKI, bridging, or unsuitable for fistula/graft.
📍 Arteriovenous (AV) Fistula
✔️ Best long-term survival, lowest infection, high flow.
❌ 4–8 wks to mature, failure to mature (≤30%), steal syndrome, aneurysm, high-output failure.
➡️ Gold standard for chronic haemodialysis.
📍 AV Graft (Synthetic ePTFE)
✔️ Can use in 2–3 weeks, option if poor veins.
❌ More infection, poorer patency than fistula, frequent re-interventions.
➡️ For patients with poor native vessels (elderly, diabetics).
📊 Infection risk: CVC > Graft > Fistula
📊 Patency/survival: Fistula > Graft > CVC
👂 Always confirm thrill + bruit before use